German IPOs off to poor start as AlzChem Pulls its €174m deal
AlzChem, the German niche chemicals producer, has postponed its €174m Frankfurt IPO, blaming difficult market conditions.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: